Preoperative dexamethasone palmitate to prevent nausea and vomiting after open surgery
Official title: Intravenous Dexamethasone Palmitate for Prophylaxis of Postoperative Nausea and Vomiting After Open Surgery
Run by Beijing Tiantan Hospital · NCT06997419 · Data updated 2026-11-12
This tests whether giving a long-acting steroid called dexamethasone palmitate before open surgery can reduce postoperative nausea and vomiting in adults aged 18–65.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | November 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 23, 2025 |
| Trial ID | NCT06997419 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 undergoing elective open spinal, chest, or abdominal surgery under general anesthesia who can give informed consent and are not pregnant or breastfeeding.
✕Probably not a fit
People allergic to dexamethasone, those who used systemic glucocorticoids within three months, or those with uncontrolled diabetes, severe heart/liver/kidney disease, active infection, systemic rheumatic disease, or pregnancy/breastfeeding are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Dexamethasone palmitate is a long-acting formulation that may provide prolonged anti-inflammatory and antiemetic effects compared with standard dexamethasone. In this interventional comparison, adults undergoing elective open spinal, chest, or abdominal surgery under general anesthesia receive preoperative dexamethasone palmitate or standard dexamethasone and are followed for postoperative nausea and vomiting and safety outcomes. The protocol excludes patients with recent systemic glucocorticoid use, severe cardiac/hepatic/renal or systemic rheumatic disease, uncontrolled diabetes, active infection, cognitive impairment or severe mental illness, and pregnant or breastfeeding individuals. Outcomes include incidence of PONV in the early postoperative period (including within 24 hours) and adverse events related to steroid exposure.
Why it matters
Potential benefit: If successful, it may offer longer-lasting prevention of postoperative nausea and vomiting with fewer side effects than standard dexamethasone.
How similar studies have gone: Standard dexamethasone is established to reduce PONV, but dexamethasone palmitate has been less studied for this indication and represents a relatively novel longer‑acting approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 to 65 years; * Providing written informed consent; * Perform elective open surgery (Spinal surgery, open chest surgery, open abdominal surgery) undergoing general anesthesia. Exclusion Criteria: * Known to be allergic to dexamethasone; * Any systemic glucocorticoids within 3 months before trial entry; * History of severe heart disease, liver/kidney failure, or systemic rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, et al); * Cognitive impairment or severe mental illness; * Uncontrolled diabetes or infectious diseases; * Pregnancy or breastfeeding.
Where it's running
-
Fang Luo
Beijing, China Recruiting
Study contacts
- Study coordinator: Fang Luo
- Email: 13611326978@163.com
- Phone: 59976661
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See how nasal ondansetron compares to IV in healthy adults
This study tests whether a nasal spray form of ondansetron delivers similar blood levels as the IV version in healthy adults.
-
Postoperative nausea, vomiting and pain after bariatric surgery in Sweden
This study looks at how often people have nausea, vomiting, and pain after bariatric surgery in Sweden and whether anesthesia type or regional blocks affect those outcomes.
-
Time to first rescue antiemetic after two dual-drug regimens for PONV in gallbladder surgery
This trial tests whether ondansetron plus metoclopramide delays the need for rescue antiemetic more than dexamethasone plus metoclopramide in adults at moderate-to-high risk undergoing laparoscopic cholecystectomy.
-
Comfort Tote to help recovery after scoliosis surgery in teens
This study tests whether a therapeutic Comfort Tote can reduce pain and anxiety after surgery for adolescent idiopathic scoliosis.
-
Menstrual cycle effects on optic nerve sheath diameter during laparoscopic gynecologic surgery
This study will try to see if menstrual cycle phase changes the optic nerve sheath size and affects postoperative nausea, vomiting, and thinking in women having elective laparoscopic gynecologic surgery.
-
High- vs low-dose propofol to reduce nausea after coronary bypass
We will see if giving higher-dose propofol during coronary artery bypass surgery reduces postoperative nausea and vomiting in adults having elective CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.